Viviana Parra-Izquierdo, Virginia Solitano, Bram Verstockt. miR-124 upregulation as a new therapeutic strategy: The evolving role of obefazimod in ulcerative colitis. // Current Opinion in Pharmacology. – 2026. – DOI: 10.1016/j.coph.2026.102659. – URL: https://doi.org/10.1016/j.coph.2026.102659
Viviana Parra-Izquierdo, Virginia Solitano, & Bram Verstockt (2026). miR-124 upregulation as a new therapeutic strategy: The evolving role of obefazimod in ulcerative colitis. Current Opinion in Pharmacology. https://doi.org/10.1016/j.coph.2026.102659
Viviana Parra-Izquierdo, et al. “miR-124 upregulation as a new therapeutic strategy: The evolving role of obefazimod in ulcerative colitis.” Current Opinion in Pharmacology, 2026. doi:10.1016/j.coph.2026.102659.
@article{ParraIzquierdo2026,
title = {miR-124 upregulation as a new therapeutic strategy: The evolving role of obefazimod in ulcerative colitis},
author = {Parra-Izquierdo, Viviana and Solitano, Virginia and Verstockt, Bram},
journal = {Current Opinion in Pharmacology},
year = {2026},
doi = {10.1016/j.coph.2026.102659},
url = {https://doi.org/10.1016/j.coph.2026.102659}
}